217 related articles for article (PubMed ID: 20649476)
41. Faulty splicing and cytoskeleton abnormalities in Huntington's disease.
Fernández-Nogales M; Santos-Galindo M; Hernández IH; Cabrera JR; Lucas JJ
Brain Pathol; 2016 Nov; 26(6):772-778. PubMed ID: 27529534
[TBL] [Abstract][Full Text] [Related]
42. Analysis of CCG repeats in Huntingtin gene among HD patients and normal populations in Japan.
Morovvati S; Nakagawa M; Osame M; Karami A
Arch Med Res; 2008 Jan; 39(1):131-3. PubMed ID: 18068007
[TBL] [Abstract][Full Text] [Related]
43. Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin.
Olson SD; Kambal A; Pollock K; Mitchell GM; Stewart H; Kalomoiris S; Cary W; Nacey C; Pepper K; Nolta JA
Mol Cell Neurosci; 2012 Mar; 49(3):271-81. PubMed ID: 22198539
[TBL] [Abstract][Full Text] [Related]
44. How does the Huntington's disease mutation damage cells?
Rubinsztein DC
Sci Aging Knowledge Environ; 2003 Sep; 2003(37):PE26. PubMed ID: 13679594
[TBL] [Abstract][Full Text] [Related]
45. Single-step scalable-throughput molecular screening for Huntington disease.
Teo CR; Wang W; Yang Law H; Lee CG; Chong SS
Clin Chem; 2008 Jun; 54(6):964-72. PubMed ID: 18403567
[TBL] [Abstract][Full Text] [Related]
46. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.
HD iPSC Consortium
Cell Stem Cell; 2012 Aug; 11(2):264-78. PubMed ID: 22748968
[TBL] [Abstract][Full Text] [Related]
47. Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!
Banoei MM; Houshmand M; Panahi MS; Shariati P; Rostami M; Manshadi MD; Majidizadeh T
Cell Mol Neurobiol; 2007 Nov; 27(7):867-75. PubMed ID: 17952586
[TBL] [Abstract][Full Text] [Related]
48. Huntington's disease: translating a CAG repeat into a pathogenic mechanism.
MacDonald ME; Gusella JF
Curr Opin Neurobiol; 1996 Oct; 6(5):638-43. PubMed ID: 8937828
[TBL] [Abstract][Full Text] [Related]
49. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
50. An ovine transgenic Huntington's disease model.
Jacobsen JC; Bawden CS; Rudiger SR; McLaughlan CJ; Reid SJ; Waldvogel HJ; MacDonald ME; Gusella JF; Walker SK; Kelly JM; Webb GC; Faull RL; Rees MI; Snell RG
Hum Mol Genet; 2010 May; 19(10):1873-82. PubMed ID: 20154343
[TBL] [Abstract][Full Text] [Related]
51. Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease.
Lee ST; Kim M
Mech Ageing Dev; 2006 May; 127(5):432-5. PubMed ID: 16527334
[TBL] [Abstract][Full Text] [Related]
52. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene.
Kovtun IV; Therneau TM; McMurray CT
Hum Mol Genet; 2000 Nov; 9(18):2767-75. PubMed ID: 11063736
[TBL] [Abstract][Full Text] [Related]
53. Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsy brain.
Dorsman JC; Smoor MA; Maat-Schieman ML; Bout M; Siesling S; van Duinen SG; Verschuuren JJ; den Dunnen JT; Roos RA; van Ommen GJ
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1061-7. PubMed ID: 10434306
[TBL] [Abstract][Full Text] [Related]
54. Huntington's disease: clinical presentation and treatment.
Novak MJ; Tabrizi SJ
Int Rev Neurobiol; 2011; 98():297-323. PubMed ID: 21907093
[TBL] [Abstract][Full Text] [Related]
55. Experimental models of HD and reflection on therapeutic strategies.
Kim J; Bordiuk OL; Ferrante RJ
Int Rev Neurobiol; 2011; 98():419-81. PubMed ID: 21907096
[TBL] [Abstract][Full Text] [Related]
56. XL PCR for the detection of large trinucleotide expansions in juvenile Huntington's disease.
Milunsky JM; Maher TA; Loose BA; Darras BT; Ito M
Clin Genet; 2003 Jul; 64(1):70-3. PubMed ID: 12791042
[TBL] [Abstract][Full Text] [Related]
57. Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells.
Feyeux M; Bourgois-Rocha F; Redfern A; Giles P; Lefort N; Aubert S; Bonnefond C; Bugi A; Ruiz M; Deglon N; Jones L; Peschanski M; Allen ND; Perrier AL
Hum Mol Genet; 2012 Sep; 21(17):3883-95. PubMed ID: 22678061
[TBL] [Abstract][Full Text] [Related]
58. Mitochondrial structural and functional dynamics in Huntington's disease.
Reddy PH; Mao P; Manczak M
Brain Res Rev; 2009 Jun; 61(1):33-48. PubMed ID: 19394359
[TBL] [Abstract][Full Text] [Related]
59. CCG polymorphisms in the huntingtin gene have no effect on the pathogenesis of patients with Huntington's disease in mainland Chinese families.
Zhang BR; Tian J; Yan YP; Yin XZ; Zhao GH; Wu ZY; Gu WH; Xia K; Tang BS
J Neurol Sci; 2012 Jan; 312(1-2):92-6. PubMed ID: 21875723
[TBL] [Abstract][Full Text] [Related]
60. Toward understanding the molecular pathology of Huntington's disease.
Wellington CL; Brinkman RR; O'Kusky JR; Hayden MR
Brain Pathol; 1997 Jul; 7(3):979-1002. PubMed ID: 9217979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
